{"id":1068481,"date":"2024-03-10T03:13:27","date_gmt":"2024-03-10T07:13:27","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/kymera-therapeutics-presents-preclinical-data-for-stat6-and-tyk2-first-in-class-oral-degrader-immunology-programs-at-the-american-academy-of\/"},"modified":"2024-08-18T11:47:50","modified_gmt":"2024-08-18T15:47:50","slug":"kymera-therapeutics-presents-preclinical-data-for-stat6-and-tyk2-first-in-class-oral-degrader-immunology-programs-at-the-american-academy-of","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kymera-therapeutics-presents-preclinical-data-for-stat6-and-tyk2-first-in-class-oral-degrader-immunology-programs-at-the-american-academy-of.php","title":{"rendered":"Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of&#8230;"},"content":{"rendered":"<p><![CDATA[KT-621 (STAT6) and KT-294 (TYK2) have the potential to provide biologics-like activity\u00a0with oral small molecule profiles]]><\/p>\n<p>Originally posted here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/03\/08\/2843184\/0\/en\/Kymera-Therapeutics-Presents-Preclinical-Data-for-STAT6-and-TYK2-First-In-Class-Oral-Degrader-Immunology-Programs-at-the-American-Academy-of-Dermatology-Annual-Meeting.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of...\">Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Originally posted here: Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/kymera-therapeutics-presents-preclinical-data-for-stat6-and-tyk2-first-in-class-oral-degrader-immunology-programs-at-the-american-academy-of.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068481","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068481"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068481"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068481\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}